Yoga intervention to improve physical performance and quality of life for cancer patients and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effectiveness of a dyadic yoga intervention aimed at enhancing physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer who are undergoing radiotherapy, along with their caregivers. Participants are divided into two groups: one receiving the yoga intervention and the other receiving educational support. The study measures improvements in physical function through the 6-minute walk test and assesses quality of life using the SF-36 questionnaire. Additionally, it explores the impact of the intervention on symptom burden and the experiences of patients and caregivers through qualitative feedback.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* PATIENT ONLY: Diagnosed with stage I-IV non-small cell lung cancer (NSCLC) or esophageal cancer and going to receive at least 3 weeks of thoracic radiotherapy (RT)
* PATIENT ONLY: Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2
* PATIENT ONLY: Able to read, write and speak English
* PATIENT ONLY: Able to provide informed consent
* PATIENT ONLY: Having a family caregiver (e.g., spouse, sibling, adult child) who assists the patient during the cancer treatment (e.g., emotional support, transportation, meal preparation, care coordination, etc) per patient self-report. Note, patients must identify a family caregiver; however, the participation of the family caregiver is optional. For caregivers to be eligible, they must be at least 18 years old; able to read, write and speak English; and able to provide informed consent. Family caregivers may consent to participate in the intervention and caregiver assessments or only the assessments based on their preference.

Exclusion Criteria:

* PATIENT ONLY: Who have regularly (self-defined) participated in a mind-body practice in the year prior to diagnosis
* PATIENT ONLY: Patients who metastatic disease involving the central nervous system

Where it's running

• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Kathrin Milbury — M.D. Anderson Cancer Center
• Study coordinator: Kathrin Milbury
• Email: kmilbury@mdanderson.org
• Phone: 713-745-2868

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring gut microbiome and fecal transplant effects on GI issues in cancer patients

  This study is testing how the gut bacteria affect stomach issues in cancer patients receiving certain treatments and whether a stool transplant can help relieve those problems.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT03819296

• Using canakinumab to prevent lung cancer in high-risk patients

  This study is testing if a medication called canakinumab can help prevent lung cancer in people who have high-risk lung nodules.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT04789681

• Respiratory muscle training before lung cancer surgery

  This study is testing if breathing exercises can help lung cancer patients recover better and avoid complications after surgery.

  Recruiting Phase 2 Roswell Park Cancer Institute · Buffalo, New York · NCT04067830

• Improving decision-making for early-stage lung cancer patients

  This study is testing whether giving early-stage lung cancer patients a quality of life fact sheet during their treatment decision-making helps them feel better about their choices compared to usual care.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT05292521

• Personalized vaccine combined with pembrolizumab for advanced solid tumors

  This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.

  Recruiting Phase 1/2 Mayo Clinic · Jacksonville, Florida · NCT05269381

• Using papaverine with chemoradiation to treat advanced non-small cell lung cancer

  This study is testing the best dose of papaverine combined with chemotherapy and radiation to see if it helps people with advanced non-small cell lung cancer live longer and control their tumors better.

  Recruiting at 2 sites Phase 1 Ohio State University Comprehensive Cancer Center · Duarte, California and 1 other locations · NCT05136846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.